Outset Medical, Inc. (NASDAQ:OM – Get Free Report) Director D Keith Grossman sold 38,117 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $3.78, for a total value of $144,082.26. Following the completion of the sale, the director now owns 47,805 […]
Outset Medical, Inc. (NASDAQ:OM – Get Free Report) Director D Keith Grossman sold 38,117 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $3.78, for a total value of $144,082.26. Following the completion of the sale, the director now owns 47,805 […]
Outset Medical (NASDAQ:OM – Get Free Report) and NeurAxis (NASDAQ:NRXS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends. Profitability This table compares Outset Medical and NeurAxis’ […]
NeurAxis (NASDAQ:NRXS – Get Free Report) and Outset Medical (NASDAQ:OM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Institutional and Insider Ownership 11.8% of NeurAxis shares […]
Outset Medical, Inc. (NASDAQ:OM – Get Free Report) has been assigned a consensus rating of “Hold” from the six research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have issued a buy recommendation on the company. […]